PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 16209213

[Flow cytometry and its application in andrological studies].

Xin-yi Xia·Shu Zhang·Yu-feng Huang
View original source ↗Export metadata ↓

Abstract

As an advanced technology, flow cytometry has its unique advantages in detecting single cells quantitatively and rapidly. So it has been used more and more widely in clinical examination. FCM offers a powerful tool and exciting opportunities for accurately evaluation of semen quality and sperm functions. And it's a new idea to apply this technology in andrological studies. This review introduces its basic principles, summaries its present and potential application in andrology studies, including separating and identifying spermatozoa, analyzing spermids structure and function, examining the biological active substances in semen and on the surface of spermids.

Explore related subjects

AndrologyAnimalsCell SeparationFlow CytometryHumansMaleSemenSperm CountSperm MotilitySpermatozoaEnglish AbstractJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Xin-yi Xia, Shu Zhang, Yu-feng Huang. 2005. [Flow cytometry and its application in andrological studies].. https://pubmed.ncbi.nlm.nih.gov/16209213/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

A new method to estimate quantitatively seminal vesicle and prostate gland contributions to ejaculate.

AIMS: We sought to optimize a quantitative noninvasive method to determine the concentration in their glands of origin of biochemical markers of compartments of the male genital tract as the first step towards validation of a novel method for estimation of drug concentrations in these male genital tract compartments. METHODS: Sixty-eight men participated. We compared four collection devices to split ejaculate into fractions. Fractions were assayed for fructose and prostate specific antigen (PSA) as unique markers of the seminal vesicle and prostate, respectively. Seminal vesicle fructose and prostatic PSA were estimated using a linear regression method, based on fructose-PSA axis intercepts, and compared with an older method which solves a simultaneous series of equations. RESULTS: A five-compartment collection device performed best with mean (95% confidence interval) PSA vs. fructose r(2) of 0.84 (0.71, 0.98, P < 0.001). Using resampling simulations, glandular PSA and fructose estimates were highly variable and often implausible when using only two fractions. Using our method, the prostate contributed 37-44% to the whole ejaculate and the seminal vesicle contributed 55-61%. The novel regression method was highly correlated (r(2) > or = 0.98) with older methods. CONCLUSIONS: We developed a noninvasive quantitative method of male genital tract biochemical marker estimation using a five-compartment tray to collect three to five ejaculate fractions. Our novel regression method is quantitative and more fully developed than older methods. This noninvasive method for determining glandular marker concentrations should be useful to provide quantitative estimates of drug concentrations in these glands.

Andrology↗